Your browser doesn't support javascript.
loading
Dynamics of Early Serum Tumour Markers and Neutrophil-to-Lymphocyte Ratio Predict Response to PD-1/PD-L1 Inhibitors in Advanced Non-Small-Cell Lung Cancer.
Tang, Yin; Cui, Yu; Li, Lin-Lin; Guan, Ya-Ping; Feng, Dong-Feng; Yin, Bei-Bei; Liang, Xue-Feng; Yin, Jing; Jiang, Rui; Liang, Jing; Sun, Ya-Hong; Wang, Jun.
Afiliação
  • Tang Y; Postgraduate Department, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, People's Republic of China.
  • Cui Y; Department of Oncology, The Third Affiliated Hospital of Shandong First Medical University (Affiliated Hospital of Shandong Academy of Medical Sciences), Jinan, 250031, People's Republic of China.
  • Li LL; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, People's Republic of China.
  • Guan YP; Shandong Lung Cancer Institute, Jinan, 250014, People's Republic of China.
  • Feng DF; Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, 250014, People's Republic of China.
  • Yin BB; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, People's Republic of China.
  • Liang XF; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, People's Republic of China.
  • Yin J; Shandong Lung Cancer Institute, Jinan, 250014, People's Republic of China.
  • Jiang R; Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, 250014, People's Republic of China.
  • Liang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, People's Republic of China.
  • Sun YH; Shandong Lung Cancer Institute, Jinan, 250014, People's Republic of China.
  • Wang J; Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, 250014, People's Republic of China.
Cancer Manag Res ; 13: 8241-8255, 2021.
Article em En | MEDLINE | ID: mdl-34754244

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article